Praveen Advani, Janssen Pharmaceuticals
Praveen Advani, Commercial Insights & Strategy Lead – US Diabetes, Janssen Pharmaceuticals
Praveen Advani has more than 18 years of experience leading US & Global market research efforts for in-line brands & new products in the Pharmaceutical Industry. Praveen is currently the Commercial Insights & Strategy Lead – US Diabetes at Janssen Pharmaceuticals. In this role, Praveen is responsible to lead the commercial excellence efforts (market research, forecasting, advanced analytics and competitive intelligence) for Invokana in the US.
Praveen has been instrumental in successfully leading global market research teams for several major global launches, most recently as the Executive Director for WW Immuno-Oncology at Bristol-Myers Squibb where he was responsible for leading all the US and International market research efforts to help successfully launch one of the fastest growing brands in the industry – Opdivo. Prior to that, he has successfully led the market research efforts for Januvia/Janumet (Diabetes, Merck) and Lantus (Diabetes, Aventis/Sanofi)
Praveen holds a MBA from Thunderbird, The American Graduate School of International Management and a Bachelors degree in Engineering from the University of Pune, India.
Lisa Courtade, Merck & Co., Inc.
Lisa Courtade, Executive Director, Global Customer & Brand Insights, Merck & Co., Inc.
A strategic, solutions oriented business leader with over 20 years of success in delivering customer insights that drive business results, Lisa has a passion for the healthcare industry and for the patients we serve. Lisa Courtade currently leads executional excellence and the transformation of insights generation at Merck as the Executive Director of Global Market Research Excellence. In this role, she and her team are responsible for driving business results and creating customer value by delivering value based innovation. Lisa was an early adopter of engaging patients in marketing research and leveraging CPG methodologies in the pharma space which contributed to receipt of the ARF’s David Ogilvy Award for creative use of insights in celebrate breakthrough moments when creative inspiration and research insights come together to produce a spectacular advertising campaign.
Lisa lives her passion for shaping the future of the industry by serving on the Marketing Research Institute International Board (MRII) as Chair of the Pharma Curriculum Committee and as an Advisory Board & Steering Committee member for the University of Georgia’s Masters in Marketing Research program, where she also serves as an alumni mentor. Lisa is an active member of the Healthcare Businesswoman’s Association (HBA) where she chaired Career Development and served as the first Global Research Director. In 2013 Lisa was awarded the PMRG’s prestigious R.R. Fordyce Award for exemplary leadership, service and dedication to the healthcare industry and the healthcare market research community.
Sandipa Dublish, Celgene
Sandipa Dublish, Senior Director Market Research Inflammation & Immunology, Celgene
Sandipa Dublish is a Decision Sciences leader in biopharmaceuticals. Prior to her position at Celgene, she was Executive Director Commercial Insights & Analytics at Alexion, a biotech specializing in rare diseases, where she built a strong Global function. Her career history includes companies such as Novartis, Bristol-Myers Squibb, and Eisai. Sandipa holds a Ph.D. in Marketing from Florida International University, Miami.
Stuart Greenberg, Bayer
Stuart Greenberg, Deputy Director, Global/Oncology Market Research, Bayer
Dr. Stuart E. Greenberg is currently Deputy Director, Global / Oncology Market Research at Bayer. His responsibilities include qualitative and quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
Ken Kirsch, Jazz Pharmaceuticals
Ken Kirsch, Senior Manager, Market Intelligence, Sleep Franchise, Jazz Pharmaceuticals
Ken Kirsch is a Pharmaceutical Market Insights, Data Analysis, and Competitive Intelligence leader and tactician. After nearly a decade as a syndicated market research, competitive intelligence and consulting lead at Scott-Levin, Ken moved on to the manufacturer side of the industry where he has led US and Global market research, analytics, and forecasting efforts for Oncology and Rare Disease therapies at Wyeth, GSK, and now Jazz Pharmaceuticals. Ken holds an MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph’s University in Philadelphia.
Richard McCloud, Pfizer
Richard McCloud, Director, Business Analytics and Insights, Pfizer
Rich has over 18 years of market research and consulting experience, providing decision support for blockbuster brands such as Celebrex, Lyrica, Cymbalta, and Xolair. His experience includes a strong history in product launches, and commercial development strategy.
Rich started his career at ZS Associates, and moved to Pfizer in 2001. His first position was on Celebrex, where he was responsible for supporting the HCP launch. He has launched the Lyrica fibromyalgia indication before moving to Genentech, where he gained biologics and medical benefit reimbursement experience working on Xolair. He also has experience working with Eli Lilly, where he worked as a consultant on Cymbalta on the very successful DTC campaigns for the Cymbalta chronic pain and depression indications. Rich returned to New York and Pfizer in 2009 to work on Lyrica, and has most recently worked on the Biosimilar team since 2013.
On biosimilars, Rich has supported the global launch of Inflectra, and the three impending launches of Oncology Biosimilar assets for Herceptin, Rituxan, and Avastin. Rich brought leadership to the team in operating plan situation assessments, developing a communal understanding of the patient journey, and finding reimbursement solutions in challenging managed care environments.
Rich earned a bachelor’s degree in Business Administration from Florida A&M University, and a Master’s degree in market research from the University of Georgia. In his (spare?) time, Rich and Tanya continually chase, encourage, and celebrate their four children (Gabrielle (13), Hendrix (9), Lillian (7), and Maxwell (2).
Mini Pinto, Merck & Co., Inc.
Mini Pinto, Executive Director, Global Market Research & Analytics, Oncology Franchise, Merck & Co., Inc.
Grace Samoil Reynolds, Celgene
Grace Samoil Reynolds, Market Insights I&I, Celgene
Grace is Market Insights I&I at Celgene. She was previously at Johnson & Johnson where she joined in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology and Pain at Ortho McNeil. Most recently, she was responsible for Market Research and Forecasting for the CNS and Pain Franchises in early Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her passion is driving innovation and future thinking.
David Rosen, Purdue Pharmaceuticals
David Rosen, Executive Director, Forecasting, Analytics & Market Research, Purdue Pharmaceuticals
David currently leads the Forecasting, Analytics and Market Research group at Purdue. David began his career at Purdue 13 years ago as a Forecasting Manager but soon worked his way up into significant additional responsibilities. Prior to joining Purdue, he was a consultant at Easton Associates, an international consulting firm specializing in product and business strategy for companies in the life sciences industries. There David led opportunity assessments, due diligence analyses and go to market strategies for numerous novel pharmaceutical therapies, medical devices and diagnostic tests. David began his pharmaceutical career at Bristol Myers Squibb, where he was selected to participate in their management development program.
David holds a Bachelor of Arts in Psychology from Cornell University. In addition, he holds a Masters of Business Administration in Healthcare Finance and Strategy and a Masters of Public Health with honors, both from Yale University.
Alexine Tranquada, Merck & Co., Inc.
Alexine Tranquada, Director Global Customer and Brand Insights, Biosimilars, Merck & Co., Inc.
Alexine Tranquada is a recognized pharmaceutical top talent with almost 20 years of experience analyzing and developing marketing strategies with entrepreneurial spirit and ownership. She is committed to optimizing performance with agility in dynamic and ambiguous environment. She has expertise in all stages of the product life cycle, multiple therapeutic areas, US and global. She has a proven history of utilizing best practices for outstanding results. She is currently leading the Global and Customer Brand Insight (GCBI) team for Merck Biosimilars Business. This business is in launch mode for the first biosimilars developed by Merck and Samsung Bioepis. Previously, Alexine was responsible for the market research and analytics for Diversified Brands and Immunology franchises. She built the capabilities of the original Diversified Brands market research function, bringing consistent high performance, deep analytical insights, high energy, efficiency and leadership skills, to develop foundational institutional building blocks for loss of exclusivity and post-patent success. Alexine held various roles of increasing responsibility including with the cardiovascular franchise (both marketing and market research), regional market research training, and Market Research Excellence.
Alexine has been with Schering-Plough and Merck for the past nine years, and was previously an Associate Vice-President at GfK. She held roles of increasing responsibility in both custom and syndicated market research, including leading the syndicated research in cardiovascular, metabolics and GI. Prior to entry in the pharmaceutical industry, Alexine worked in basic animal-model laboratory research at the University of Pittsburgh.
Alexine has a Bachelor of Science from McGill University (in Microbiology and Immunology with a minor in Management) and an MBA from the University of Pittsburgh with concentrations in Marketing and Strategy. Outside of work, Alexine is an avid runner and mother of three children, Ella (age 13), Calvin (age 10) and Miles (age 6).
Jeet Uppal, Bristol-Myers Squibb
Jeet Uppal, Worldwide Lead – Global Market Research Capabilities, Bristol-Myers Squibb
Jeet is currently the Worldwide Lead, Market Research Capabilities & Enablement at Bristol-Myers Squibb. He leads a team of Researchers and his group responsibilities include managing tracking studies across all therapeutic areas and regions, social listening, MR agency management, knowledge management, training and best practice. Earlier he also established and led the oncology patient chart audit at BMS.
Prior to BMS, Jeet was the Global Group Director for Global Market Research at Zoetis. Jeet led a global team of market researchers and was responsible for Market Research across all species, regions and new products. Jeet joined Pfizer in 2003 as Director, Global Market Research. Pfizer spun off to Zoetis in 2012.
Jeet worked in Pfizer Human Pharmaceutical Opthalmology and Oncology disease areas. He led Pfizer Opthalmology’s market research US and worldwide teams for Glaucoma (Xalatan & Xalacom), Macular degeneration (Macugen) and New Products (Dry eye, DME, strategic evaluation of new disease areas and licensing/development opportunities). Prior to moving to Animal Health, Jeet worked in Pfizer’s Oncology TA and led market research for Oncology New Products and Business Development.
Prior to joining Pfizer, Jeet worked for 10 years in marketing and market research at premier companies including Procter & Gamble, PepsiCo International and Reliant Energy. Jeet started his market research career at Procter & Gamble, where he led core projects across P&G’s Paper, Home-Care and New Ventures business units. Jeet has led market research efforts on multiple billion dollar plus brands like Bounty, Luvs, Pampers, Cascade and Dawn, leading both established business and new ventures. Jeet led PepsiCo’s international market research for the core Pepsi brands. At Reliant Energy, Jeet led direct marketing and market research for the deregulating utility market.
Jeet received his MBA from University of Chicago with specialization in strategy and finance. He holds a Masters in Environmental Engineering from Pennsylvania State University.